newsfilter
← Latest News
GlobeNewswire·

Immuron Announces Travelan® Clinical Trial Update

Highlights: Travelan® (IMM-124E) Phase 2 Clinical Study Report submitted to the FDATravelan® (IMM-124E) Phase 2 Clinical Study Statistically Significant Immunology ResultsTravelan® (IMM-124E) Phase 2